Please login to your online account to display your discounted pricing

Promega™ TNT™ Coupled Reticulocyte Lysate Systems

Single-tube, coupled transcription/translation systems for eukaryotic in vitro translations

$202.23 - $756.49

Specifications

For Use With (Application) GST pull-downs, Gel shift assays, co-immunoprecipitation, characterization of Protein modifications, Protein-RNA interactions, Protein activity studies, confirmation of gene products, Protein truncation test (PTT)
View More Specs
Includes:  TNT Rabbit Reticulocyte Lysate, Appropriate TNT polymerase, Control DNA, TNT Reaction Buffer, Luciferase assay wells, Luciferase assay reagent, Amino acid mixtures
Products
Catalog Number Mfr. No. Includes Quantity Price Quantity    

PR-L4600

 
promega™
L4600
Each for $727.60

PR-L4610

 
promega™
L4610
Each for $731.88

PR-L5010

 
promega™
L5010
Each for $731.88

PR-L4950

 
promega™
L4950
Each for $731.88

PR-L5020

 
promega™
L5020
Each for $756.49

PR-L4611

 
promega™
L4611
200μL TNT™ Rabbit Reticulocyte Lysate, 20μL TNT™ Reaction Buffer, 20μL TNT™ T7 or SP6 RNA Polymerase, 5μg Luciferase T7 or SP6 co 8 Reactions - Trial Size Each for $202.23

PR-L4601

 
promega™
L4601
200μL TNT™ Rabbit Reticulocyte Lysate, 20μL TNT™ Reaction Buffer, 20μL TNT™ T7 or SP6 RNA Polymerase, 5μg Luciferase T7 or SP6 co 8 Reactions - Trial Size Each for $202.23
Description & Specifications

Specifications

For Use With (Application) GST pull-downs, Gel shift assays, co-immunoprecipitation, characterization of Protein modifications, Protein-RNA interactions, Protein activity studies, confirmation of gene products, Protein truncation test (PTT)

  • Produce data in as little as five to six hours, half the time of conventional two-step systems
  • Provide two to six times the protein of standard translation reactions
  • Compatible with linear or circular templates (T7 and T3 systems only; SP6 systems should be used with circular DNA only)
  • Rigorously quality controlled to ensure the highest level of transcription/translation
  • Available in configurations that permit co-expression of genes under the control of different phage polymerase promoters

U.S. Patents 5,324,637 and 5,492,817; Australian Patent 660329.
U.S. Patents 5,641,641; 5,650,289; and 5,814,471; Australian Patent 649289.
Australian Patents 616881 and 641261 and other pending and issued patents, which claim vectors encoding a portion of human placental ribonuclease inhibitor, are exclusively licensed to Promega Corporation.
The method of recombinant expression of Coleoptera luciferase is covered by U.S. Patents 5,583,024; 5,674,713; and 5,700,673. A license (from Promega for research reagent products and from The Regents of the University of California for all other fields) is needed for any commercial sale of nucleic acid contained within or derived from this product.